DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Transactions / A••••• H••••••••• P••••••••
A•••••• Sells A••••• H••••••••• P•••••••• to C•••••••
Exit to a strategic buyerclosedannounced Mar 2, 2023closed Mar 2, 2023Fact
What happened
- Platform
- not an add-on on record
- Control
- unknown
- Share acquired
- unknown
- Industry
- healthcare / healthcare
- Target location
- unknown
- Seller kind
- Sponsor
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
8 named
Buy side
- “A•••••• Capital Partners (“A••••••”) announced that it has sold A••••• H••••••••• P•••••••• (“A•••••”) to C•••••••• I••• (“C•••••••”).”
- “G••••• A••, an Operating Partner of A••••••, commented, “Following the carve-out of A••••• from its prior corporate parent, we were thrilled to work alongside a talented leadership team to implement, improve, and outperform our investment objectives.””
Sell side
- “A•••••• Capital Partners is a leading private equity firm that specializes in investments in industrial growth and healthcare companies.”
Advisory side
- W•••••• B•••• • C••••••• L•••••Financial adviserconfirmed“W•••••• B•••• & Company LLC acted as financial advisor to A••••• and Kirkland & Ellis LLP served as legal counsel.”
- D•••••• L••Legal adviserconfirmed“D•••••• L•• served as legal counsel to C••••••• with respect to the transaction.”
Side not stated
- ““A•••••’s capabilities will be a strong complement to C•••••••’s existing portfolio,” said S•••• T•••••, CEO of C•••••••.”
- ““We are grateful for the support of A•••••• over the past three years as we further established A••••• as the go-to solution provider in the pharmaceutical, nutraceutical, and diagnostic industries,” said M••••••• B••••••, President and Managing Director of A•••••.”
- “A•••••• Capital Partners (“A••••••”) announced that it has sold A••••• H••••••••• P•••••••• (“A•••••”) to C•••••••• I••• (“C•••••••”).”
Evidence
“A•••••• Capital Partners (“A••••••”) announced that it has sold A••••• H••••••••• P•••••••• (“A•••••”) to C•••••••• I••• (“C•••••••”).”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 14, 2026